The Next Preventive Frontier May Be Right Under Our Noses

For something we rely on every minute of every day, the nose is remarkably overlooked.

That was the central theme of a recent Vital Stuff conversation between podcaster Gail Lebovic, MD, and Karen Parker-Davidson, DHA-APRN.  This exchange underscored a growing realization in medicine: nasal health is foundational to overall health, not an afterthought.

“We think about breathing only when something goes wrong,” Lebovic noted. “But oxygen is the one thing we can’t live without—even briefly.” The route that oxygen takes, Parker-Davidson emphasized, matters far more than most people realize.

Gail Lebovic, MD
Karen Parker-Davidson, DHA-APRN

The Nose as a Functional and Diagnostic Organ—Not Just a Passageway

Parker-Davidson, a clinician with more than three decades of experience across critical care, ENT, aerospace medicine, and medical devices, reframed the nose as a reactive organ—one with more than 60 distinct functions. Its job is not merely to move air, but to filter, humidify, warm, and regulate airflow before it reaches the lungs.

Nasal resistance is slow and sneaky, she explained, and is often mistaken for congestion. Congestion is acute and obvious. Resistance is cumulative, and insidious—quietly impairing airflow, oxygen exchange, sleep quality, posture, and even facial development over time.

“We can be breathing and still not be breathing well,” Parker-Davidson said.

Measuring What Patients Feel

That gap between subjective sensation and objective function, aka the Weber-Fechner Law, is where innovation enters the picture. Lebovic described how her work with NasoClenz revealed a consistent pattern: people reported they could “breathe better” almost immediately after using the nasal-cleansing gel—but there was no reliable way to measure that improvement.

Enter 4-phase rhinomanometry, a non-invasive standard diagnostic tool aimed at objectively evaluating nasal function. The non-invasive technique measures airflow and pressure in seconds during nasal breathing.  When Parker-Davidson applied it, the results were striking. Objective measurements showed a reduction of approximately 15% in nasal resistance within minutes of using NasoClenz.

“It wasn’t just a feeling,” Parker-Davidson said. “The data showed real physiologic change.”

The gel works by gently interacting with the nasal tissues inside the nose, more commonly known as the nasal turbinates. The nasal turbinates are particularly rich in histamine-responsive tissue and tend to swell during allergies or congestion. The application of NasoClenz helps airflow move more smoothly, while preserving the resistance needed for proper nasal function and lung protection.

A Post-Pandemic Nasal Awakening

Both clinicians agreed that the COVID-19 pandemic accelerated awareness of nasal health. With most respiratory viruses entering through the nose, the organ’s role as a biological gatekeeper became impossible to ignore.

“We’re in the middle of a nasal renaissance,” Lebovic said. “The nose is finally getting the respect it deserves.”

For Parker-Davidson, the goal now is education, translating complex airway science into practical, preventive strategies that help people breathe easier, sleep better, and perform better.

Breathing, after all, is the most basic act of survival. As this conversation made clear, how we breathe—and how well—may shape far more of our health than we ever imagined.


ICU Study Finds Simple Adhesive Step Improves Line Security, Cuts Costs

A Simple Idea, Proven by Rigorous Science


A multicenter randomized controlled trial published in Critical Care Medicine is drawing global attention for its practical impact.

The STICKY Trial, led by Australian researcher Nicole Marsh, RN, PhD, found that adding gum mastic liquid adhesive (Mastisol®) to standard jugular central-line dressings:

  • Cut premature dressing failure nearly in half
  • Extended wear time more than two-fold
  • Saved hospitals money
  • And showed promising signals for infection prevention

“Maintaining effective dressing securement of central venous catheters in intensive care is a
clinical priority,” says Dr. Marsh. “Our study demonstrated that Mastisol kept dressings intact longer and reduced unnecessary changes. That means the insertion wound stays continually protected from contamination, and the risk of catheter dislodgement is reduced as well.”

Across four Australian ICUs, 160 critically ill patients with jugular central venous catheters
(CVCs) were enrolled.

Premature dressing failure fell from 50 percent in the control group to 28 percent with Mastisol. Median dressing life increased from 23.8 hours to 58.5 hours, producing an average savings of AUD $11 per patient in material and labor costs.

Continue reading “ICU Study Finds Simple Adhesive Step Improves Line Security, Cuts Costs”

PICC Excellence Launches Ultrasound PIV Mastery Program

Insertion of a peripheral intravenous catheter is the most commonly performed invasive medical procedure among hospitalized patients. When coupled with ultrasound technologies for vascular visualization, well trained clinicians achieve greater first-time procedural success for peripheral IV insertions.

Nancy Moureau, RN, PhD, CRNI, CPUI, VA-BC

According to vascular access expert Nancy Moureau, RN, PhD, CRNI, CPUI, VA-BC, inconsistent and fragmented training can make it difficult for clinicians to establish competency and master the skills needed to perform successful ultrasound-guided peripheral IV insertions.

To address the lack of standardized UGPIV training, Moureau and her team at PICC Excellence developed a comprehensive training program, which recently became the first educational program to be recognized with a Seal of Approval from the Infusion Nurses Society. The INS Seal of Approval is designed to reflect the credibility of education, competency-based training and content that adheres to INS standards for infusion-related practices (see sidebar below).

Continue reading “PICC Excellence Launches Ultrasound PIV Mastery Program”

The Evolution of Thought Leadership in the MedTech Industry: Insights from Jeff Jones

In the rapidly advancing world of medical technology, establishing credibility and trust is paramount. And one of the best ways to establish that credibility is to seek—and follow—the advice of prominent experts in a particular medtech field. Combined with a strategic public relations strategy, such key opinion leaders (KOLs) can then help raise awareness and provide an invaluable validation of a technology’s importance and value. Together, thought leaders and PR experts enable businesses to gain media exposure, present results at scientific meetings, and secure speaking engagements at industry conferences, thus raising the companies’ visibility and credibility.

Jeffrey Jones, Managing Partner at The Deerborne Group, a global diagnostics and life sciences consulting firm, has learned the importance of key opinion leaders over the course of a long and successful career at both Fortune 500 companies like Abbott, Bayer, and Quest Diagnostics and venture-backed startups like Agendia, which offers genomic testing for breast cancers. Here are his insights:

Continue reading “The Evolution of Thought Leadership in the MedTech Industry: Insights from Jeff Jones”

Vascular Access Group on LinkedIn

LinkedIn is a tremendous information resource for professionals. But for the most part those in nursing – especially professionals with an interest in infusion therapy and vascular access – have been underrepresented on LinkedIn.

No more! We’ve just established a new forum for vascular access professionals on LinkedIn. It’s open to anyone interested in the field, who wants to read or post about issues and questions pertaining to vascular access.

We hope you’ll consider joining the group. To do so, go to http://www.LinkedIn.com. Join LinkedIn if you are not already a member, then search the “Groups” function for the phrase “vascular access.”

Thanks, and we hope to see you over on LinkedIn soon.

Patient Safety Gets a Certification Program — At Last

More than a decade after patient safety hit the national agenda with the publication of the Institute of Medicine’s “To Err Is Human” report, someone is finally putting together a certification program for professionals involved in ensuring patient safety.

The leading group in this field, the National Patient Safety Foundation (NPSF), has just launched the certification program. It’s designed to standardize a curriculum, elevate the profession and share best practices.

“Patient safety is a top priority for our healthcare system,” said Dr. Lucian L. Leape, chair of the Lucian Leape Institute at NPSF. “But we will not be able to truly move the needle until those who are involved in the practice have the knowledge base necessary to do the job. The certification program is an essential element in that quest.”

Dr. David Shulkin attempted as far back as the late 1990s to highlight the profession through creation of the Patient Safety Officers Society. PSOS got some early traction but hasn’t been active for several years. Dr. Shulkin is now president of Morristown (N.J.) Memorial Hospital and vice president of its parent, Atlantic Health.

This time around, NPSF reports, membership in the American Society of Professionals in Patient Safety is open to professionals whose primary responsibility is patient safety as well as others across the healthcare disciplines.

Our view: The patient safety field represents the essential nexus of numerous healthcare fields, and NPSF’s new initiative represents a major step forward in better protecting patients. More details at http://npsf.org/pr/pressrel/2010-12-22.php.

 

TV Appearance by Greg Dennis

Greg Dennis got his 10 seconds of fame on Vermont television over the last few days. His comments about the opening of the new bridge in downtown Middlebury, Vt., where Greg lives, were featured in a report on Channel 5, the local NBC affiliate. The Middlebury bridge was a joint effort between the town and Middlebury College. http://www.wptz.com/news/25542401/detail.html

PR Spending Rises, Even in Recession

The respected Economist magazine reports that even in this horrible recession, corporate spending on public relations is on the rise.

“According to data from Veronis Suhler Stevenson (VSS), a private-equity firm, spending on public relations in America grew by more than 4% in 2008 and nearly 3% in 2009 to $3.7 billion,” the magazine writes. “That is remarkable when compared with other forms of marketing. Spending on advertising contracted by nearly 3% in 2008 and by 8% in the past year. PR’s position looks even rosier when word-of-mouth marketing, which includes services that PR firms often manage, such as outreach to bloggers, is included. Spending on such
things increased by more than 10% in 2009.”

Why the rise?

Part of the answer is that PR is so cost-effective, at a time when
everyone is carefully counting dollars. In healthcare, ad dollars have been shrinking because advertising is very costly and far less credible than media coverage and other awareness-building achievements generated by good PR. Moreover, the increasing need for businesses to be involved in social media — where PR shines in delivering the message — also drives investments.

Excelsior, Novian Added as New Clients

We’re happy to report that even in the economic downturn, we’ve added two new clients:

* Excelsior Medical is a leading maker of prefilled catheter flush syringes. The company is also launching an exciting new technology called SwabCap™. This product promises to pioneer more effective prevention of potentially deadly catheter-related bloodstream infections.

SwabCap provides passive, verifiable disinfection of the top and threads of luer access valves. These valves are a critical part of providing IV medication and nutrition. Both the Joint Commission and SHEA/IDSA Compendium have new guidelines calling for hospitals to have a specific disinfection protocol– meaning Excelsior expects strong demand for SwabCap as part of the company’s focus on preventing intra-luminal contamination of catheters. http://www.ExcelsiorMedical.com

*Novian Health makes the Novilase™ laser ablation device to treat fibroadenomas of the breast. These non-cancerous lumps are a troubling breast health problem for many women. Novilase provides a minimally invasive alternative to surgical lumpectomy, with no scarring and less infection risk. Novilase is FDA-cleared for treating fibroadenomas. http://novianhealth.com